| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af00fdd02e34a80caaf6e594e7cc27e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-20022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16234
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate |
2009-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbb9713bc0e64bf1c7ba70da90f8322d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6bcb3a749b2f326705651b4584a6b0 |
| publicationDate |
2011-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2296700-A2 |
| titleOfInvention |
Intranasal administration of receptor-binding ligands or genes encoding such ligands as a therapeutic regimen for mitigating infections caused by respiratory pathogens |
| abstract |
The present invention relates to a receptor-binding ligand either administered intranasally or expressed following intranasal administration from a recombinant vector that expresses at least one therapeutic ligand which binds to a receptor necessary for infection by a respiratory pathogen. The receptor-binding ligand in the respiratory tract not only confers rapid protection as a therapeutic drug but also elicits long-term protective immunity as a vaccine against a respiratory pathogen. This regimen is not compromised by the emergence of drug resistance because the receptor for any pathogen can be blocked by the pathogen's own receptor-binding ligand. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10786568-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11578341-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11535665-B2 |
| priorityDate |
2008-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |